DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

RPG Life Sciences Limited — Resignation of Director/KMP/SMP

NSE 1 hr ago·14 Aug 2026, 7:39 pm

RPG Life Sciences

A key change has taken place in the leadership of RPG Life Sciences Limited. The company has announced the resignation of a director or key managerial personnel. This development may have implications for the company's strategy and operations.

The resignation could lead to a shift in the company's decision-making process and may impact investor confidence. It is essential for investors to monitor the situation and watch for any further announcements from the company.

Investors should keep an eye on the company's future statements and announcements to understand the impact of this change on RPG Life Sciences Limited's overall performance and direction.